摘要
目的评估经尿道前列腺电气化切除术治疗高龄、高危患者的安全性及疗效。方法回顾性分析经尿道前列腺电气化切除术治疗的138例80岁以上高危良性前列腺增生症（benign prostatic hyperplasia，BPH）患者的临床资料。结果138例患者手术时间32—68min（平均42min）。电切前列腺组织42～155g（平均76g）；术中失血9—185ml（平均38m1）。术中未发生经尿道电切综合征、大出血。国际前列腺症状评分（international prostatic symptom score，IPSS）平均值由术前34．8降到7．5，平均Qmax由6．89ml／s增加至15．67ml／s。随访3～72个月，平均16．8个月。全部病例术后均排尿通畅。所有患者术后均未有心、脑、肝、肾等系统疾病加重。结论只要术前积极控制并发症，医师技术娴熟，经尿道前列腺电气化切除术是当今治疗80岁以上高危BPH的安全、有效的方法。
Objective To evaluate the safety and efficacy of transurethral electrovaporization of the prostate（TUVP） in senile and high risk patients of benign prostatic hyperplasia （BPH）. Methods The clinical data of 138 senile and high risk BPH patients treated by TUVP were analysed retrospectively. Results Mean weight of resected tissue was 76 （ range 42 - 155 ） g and mean operation time was 42 （ range 32 - 68） min. The blood loss during operation was 9 - 185 （ average 38 ） ml. Postoperative mean maximal urinary flow rate was significantly increased, and the mean international prostatic symptom score （IPSS） was significantly decreased. The follow-up period was 3 -72 months and all patients could pass urine smoothly. The preoperative concurrent diseases of heart, brain, liver and kidney etc. were not aggravated after TUVP operation. Conclusion TUVP can be applied to senile（ ≥80 years old） and high risk BPH patients with safety and satisfied efficacy.
出处
《第三军医大学学报》
CAS
CSCD
北大核心
2007年第2期173-175,共3页
Journal of Third Military Medical University
关键词
前列腺增生症
经尿道前列腺电气化切除术
benign prostatic hyperplasia
transurethral electrovaporization of prostate
